查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球基質血管分割市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按產品、按應用、按最終用戶、按地區
市場調查報告書
商品編碼
1398762

全球基質血管分割市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按產品、按應用、按最終用戶、按地區

Stromal Vascular Fraction Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 183 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

預計 2024 年全球基質血管成分 (SVF) 市場規模約為 9,600 萬美元，到 2031 年底可望達到約 1.31 億美元。 新型自動化即時護理 (POC) 設備的開發、成本效益以及 SVF 療法的日益普及推動了市場的發展。

包括 SVF 在內的幹細胞療法在醫療保健領域具有巨大潛力。 然而，SVF 療法的實際實施在許多醫療機構面臨知識、基礎設施和物資方面的挑戰。 為了克服這些障礙，公司和研究機構正在開發自動化 POC 設備，以簡化 SVF 分離流程。 這些設備在消除運輸需求、降低處理成本和最小化對組織的操作方面具有顯著的優勢。 降低成本、易用性和改善患者治療效果是市場成長的關鍵驅動力。

SVF 市場成長的挑戰包括監管合規問題和先進基礎設施的需求。 過去，一些醫療器材製造商將其產品推向監管界限之外，影響了患者對脂肪幹細胞治療的認知和採用。 遵守法規對於確保病患安全至關重要。

由於無塵室設施、專業設備、技術能力和 cGMP 合規性等基礎設施要求，SVF 的實施僅限於大型城市醫院。 要獲得這些程序的報銷仍然很困難，從而降低了市場滲透率。

本報告調查了全球基質血管成分市場，並提供了市場概述，以及按產品、應用、最終用戶、地區劃分的趨勢以及進入市場的公司的競爭趨勢。

目錄

第 1 章執行摘要

第二章市場概述

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影響分析
  • 烏克蘭和俄羅斯之間衝突的影響
  • 經濟概況
  • 杵分析

第 3 章 2018-2031 年全球基質血管成分市場前景

  • 2018-2031 年全球基質血管分離市場前景（按產品、價值（百萬美元））
  • 2018-2031 年全球基質血管分離市場前景（按應用、價值（百萬美元））
  • 2018-2031 年全球基質血管分割市場前景（以最終用戶劃分）價值（百萬美元）
  • 2018-2031 年全球基質血管分割市場前景（按地區、價值（百萬美元））

第 4 章 2018-2031 年北美基質血管成分市場前景

第 5 章歐洲基質血管成分市場前景，2018-2031

第 6 章亞太基質血管分割市場展望，2018-2031

第 7 章拉丁美洲基質血管分割市場展望，2018-2031

第 8 章中東與非洲基質血管分離市場展望，2018-2031

第九章競爭態勢

  • 按細分和使用情況劃分的熱圖
  • 按製造商和應用程式劃分的熱圖
  • 2023 年公司市佔率分析
  • 競爭力儀表板
  • 公司簡介
    • Cytori Therapeutics Inc.
    • IntelliCell BioSciences Inc.
    • Cellular Biomedicines Group, Inc.
    • GE Healthcare (Biosafe Group SA)
    • Lifecell Corporation (Allergen PLC)
    • Tissue Genesis Inc.
    • InGeneron, Inc.
    • Human med AG
    • MEDICAN CO., LTD
    • Hairline International
    • Genesis Biosystems, Inc.
    • iXCells Biotechnologies USA, LLC
    • Kyocera Corporation
    • Medikan International Inc

第 10 章附錄

簡介目錄

The global Stromal Vascular Fraction (SVF) market, with revenues of approximately US$ 96 million in 2024, is on track to achieve a valuation of around US$ 131 million by the end of 2031. The market's growth is being driven by the development of new automated Point-of-Care (POC) devices, cost-effectiveness, and the rising adoption of SVF therapies.

Driving Growth: Development of Automated POC Devices

Stem cell therapies, including SVF procedures, hold great promise in healthcare. However, the practical implementation of SVF therapies faces challenges in terms of knowledge, infrastructure, and supplies in many healthcare facilities. To overcome these obstacles, companies and research laboratories are developing automated POC devices to streamline SVF isolation processes. These devices eliminate the need for transport, reduce processing costs, and offer significant advantages in terms of minimal manipulation of tissue. Cost savings, ease of use, and improved patient outcomes are key drivers of market growth.

Challenges: Regulatory Compliance and Infrastructure

Challenges to SVF market growth include regulatory compliance issues and the need for advanced infrastructure. In the past, some medical device companies pushed products beyond regulatory boundaries, impacting patient perceptions and adoption of adipose-derived stem cell therapies. Compliance with regulations is critical to ensure patient safety.

Infrastructure requirements, such as clean room facilities, specialized equipment, technical capabilities, and adherence to cGMP practices, limit SVF implementation to major hospitals in urban areas. Obtaining reimbursement for these procedures remains challenging, reducing market penetration.

Country-wise Insights

United States: Extensive Clinical Trials Fuel Demand

The U.S. market is booming due to a massive pipeline of SVF-derived cell therapies and extensive clinical trials assessing their efficacy for various purposes. The increasing number of clinical trials drives demand for SVF products, including proprietary SVF isolation devices and consumables.

India: Rise in Research and Development Activities

India is emerging as a lucrative market due to increased research and development activities focused on innovative SVF technologies. The expansion of private hospitals in rural areas contributes to market growth, making the Asian region attractive.

Germany: Musculoskeletal Disorders Drive Demand

Germany's growing aging population and rising awareness of stem cell therapy, particularly in musculoskeletal disorders like osteoarthritis, position the country as a prominent market for SVF treatments. Legal constraints on stem-cell research and therapy are expected to relax, further boosting market growth.

Competitive Landscape

Key market players emphasize product launches, strategic alliances, mergers, acquisitions, and facility expansions to enhance their market presence.

Key Companies in the Stromal Vascular Fraction (SVF) Market:

  • Cytori Therapeutics Inc.
  • IntelliCell BioSciences Inc.
  • Cellular Biomedicines Group, Inc.
  • GE Healthcare (Biosafe Group SA)
  • Lifecell Corporation (Allergen PLC)
  • Tissue Genesis Inc.
  • InGeneron, Inc.
  • Human med AG
  • MEDICAN CO., LTD
  • Hairline International
  • Genesis Biosystems, Inc.
  • iXCells Biotechnologies USA, LLC
  • Kyocera Corporation
  • Medikan International Inc.

Key Segments Covered in Manufacturing of Industry Research

Product:

  • SVF Aspiration Products
  • SVF Transfer Products
  • SVF Isolation Products
  • Enzymatic Isolation Products
  • Non-enzymatic Isolation Products
  • Automated POC Devices

Application:

  • Cosmetic Applications
  • Orthopedic Applications
  • Soft Tissue Applications
  • Others

End User:

  • Hospitals
  • Specialty Clinics
  • Stem Cell Banks/Laboratories
  • Others

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Stromal Vascular Fraction Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Stromal Vascular Fraction Market Outlook, 2018 - 2031

  • 3.1. Global Stromal Vascular Fraction Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. SVF Aspiration Products
      • 3.1.1.2. SVF Transfer Products
      • 3.1.1.3. SVF Isolation Products
        • 3.1.1.3.1. Enzymatic Isolation Products
        • 3.1.1.3.2. Non-enzymatic Isolation Products
        • 3.1.1.3.3. Automated POC Devices
  • 3.2. Global Stromal Vascular Fraction Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Cosmetic Applications
      • 3.2.1.2. Orthopedic Applications
      • 3.2.1.3. Soft Tissue Applications
      • 3.2.1.4. Others
  • 3.3. Global Stromal Vascular Fraction Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Hospitals
      • 3.3.1.2. Specialty Clinics
      • 3.3.1.3. Stem Cell Banks/Laboratories
      • 3.3.1.4. Others
  • 3.4. Global Stromal Vascular Fraction Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Stromal Vascular Fraction Market Outlook, 2018 - 2031

  • 4.1. North America Stromal Vascular Fraction Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. SVF Aspiration Products
      • 4.1.1.2. SVF Transfer Products
      • 4.1.1.3. SVF Isolation Products
        • 4.1.1.3.1. Enzymatic Isolation Products
        • 4.1.1.3.2. Non-enzymatic Isolation Products
        • 4.1.1.3.3. Automated POC Devices
  • 4.2. North America Stromal Vascular Fraction Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Cosmetic Applications
      • 4.2.1.2. Orthopedic Applications
      • 4.2.1.3. Soft Tissue Applications
      • 4.2.1.4. Others
  • 4.3. North America Stromal Vascular Fraction Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hospitals
      • 4.3.1.2. Specialty Clinics
      • 4.3.1.3. Stem Cell Banks/Laboratories
      • 4.3.1.4. Others
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis
  • 4.4. North America Stromal Vascular Fraction Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. U.S. Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 4.4.1.2. U.S. Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 4.4.1.3. U.S. Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 4.4.1.4. Canada Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 4.4.1.5. Canada Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 4.4.1.6. Canada Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Stromal Vascular Fraction Market Outlook, 2018 - 2031

  • 5.1. Europe Stromal Vascular Fraction Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. SVF Aspiration Products
      • 5.1.1.2. SVF Transfer Products
      • 5.1.1.3. SVF Isolation Products
        • 5.1.1.3.1. Enzymatic Isolation Products
        • 5.1.1.3.2. Non-enzymatic Isolation Products
        • 5.1.1.3.3. Automated POC Devices
  • 5.2. Europe Stromal Vascular Fraction Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Cosmetic Applications
      • 5.2.1.2. Orthopedic Applications
      • 5.2.1.3. Soft Tissue Applications
      • 5.2.1.4. Others
  • 5.3. Europe Stromal Vascular Fraction Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals
      • 5.3.1.2. Specialty Clinics
      • 5.3.1.3. Stem Cell Banks/Laboratories
      • 5.3.1.4. Others
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. Europe Stromal Vascular Fraction Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.2. Germany Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.3. Germany Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.4. U.K. Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.5. U.K. Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.6. U.K. Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.7. France Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.8. France Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.9. France Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.10. Italy Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.11. Italy Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.12. Italy Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.13. Turkey Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.14. Turkey Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.15. Turkey Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.16. Russia Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.17. Russia Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.18. Russia Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.19. Rest of Europe Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.20. Rest of Europe Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.21. Rest of Europe Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Stromal Vascular Fraction Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Stromal Vascular Fraction Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. SVF Aspiration Products
      • 6.1.1.2. SVF Transfer Products
      • 6.1.1.3. SVF Isolation Products
        • 6.1.1.3.1. Enzymatic Isolation Products
        • 6.1.1.3.2. Non-enzymatic Isolation Products
        • 6.1.1.3.3. Automated POC Devices
  • 6.2. Asia Pacific Stromal Vascular Fraction Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Cosmetic Applications
      • 6.2.1.2. Orthopedic Applications
      • 6.2.1.3. Soft Tissue Applications
      • 6.2.1.4. Others
  • 6.3. Asia Pacific Stromal Vascular Fraction Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals
      • 6.3.1.2. Specialty Clinics
      • 6.3.1.3. Stem Cell Banks/Laboratories
      • 6.3.1.4. Others
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Asia Pacific Stromal Vascular Fraction Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.2. China Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.3. China Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.4. Japan Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.5. Japan Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.6. Japan Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.7. South Korea Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.8. South Korea Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.9. South Korea Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.10. India Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.11. India Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.12. India Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.13. Southeast Asia Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.14. Southeast Asia Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.15. Southeast Asia Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.16. Rest of Asia Pacific Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.17. Rest of Asia Pacific Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.18. Rest of Asia Pacific Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Stromal Vascular Fraction Market Outlook, 2018 - 2031

  • 7.1. Latin America Stromal Vascular Fraction Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. SVF Aspiration Products
      • 7.1.1.2. SVF Transfer Products
      • 7.1.1.3. SVF Isolation Products
        • 7.1.1.3.1. Enzymatic Isolation Products
        • 7.1.1.3.2. Non-enzymatic Isolation Products
        • 7.1.1.3.3. Automated POC Devices
  • 7.2. Latin America Stromal Vascular Fraction Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
      • 7.2.1.1. Cosmetic Applications
      • 7.2.1.2. Orthopedic Applications
      • 7.2.1.3. Soft Tissue Applications
      • 7.2.1.4. Others
  • 7.3. Latin America Stromal Vascular Fraction Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals
      • 7.3.1.2. Specialty Clinics
      • 7.3.1.3. Stem Cell Banks/Laboratories
      • 7.3.1.4. Others
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Latin America Stromal Vascular Fraction Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 7.4.1.2. Brazil Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 7.4.1.3. Brazil Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.4.1.4. Mexico Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 7.4.1.5. Mexico Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 7.4.1.6. Mexico Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.4.1.7. Argentina Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 7.4.1.8. Argentina Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 7.4.1.9. Argentina Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.4.1.10. Rest of Latin America Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 7.4.1.11. Rest of Latin America Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 7.4.1.12. Rest of Latin America Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Stromal Vascular Fraction Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Stromal Vascular Fraction Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. SVF Aspiration Products
      • 8.1.1.2. SVF Transfer Products
      • 8.1.1.3. SVF Isolation Products
        • 8.1.1.3.1. Enzymatic Isolation Products
        • 8.1.1.3.2. Non-enzymatic Isolation Products
        • 8.1.1.3.3. Automated POC Devices
  • 8.2. Middle East & Africa Stromal Vascular Fraction Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Cosmetic Applications
      • 8.2.1.2. Orthopedic Applications
      • 8.2.1.3. Soft Tissue Applications
      • 8.2.1.4. Others
  • 8.3. Middle East & Africa Stromal Vascular Fraction Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Specialty Clinics
      • 8.3.1.3. Stem Cell Banks/Laboratories
      • 8.3.1.4. Others
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Middle East & Africa Stromal Vascular Fraction Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.4.1.2. GCC Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.3. GCC Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.4.1.4. South Africa Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.4.1.5. South Africa Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.6. South Africa Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.4.1.7. Egypt Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.4.1.8. Egypt Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.9. Egypt Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.4.1.10. Nigeria Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.4.1.11. Nigeria Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.12. Nigeria Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.4.1.13. Rest of Middle East & Africa Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.4.1.14. Rest of Middle East & Africa Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.15. Rest of Middle East & Africa Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. By Segment 3 vs by Application Heat map
  • 9.2. Manufacturer vs by Application Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Cytori Therapeutics Inc.
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. IntelliCell BioSciences Inc.
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. Cellular Biomedicines Group, Inc.
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. GE Healthcare (Biosafe Group SA)
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. Lifecell Corporation (Allergen PLC)
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. Tissue Genesis Inc.
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. InGeneron, Inc.
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. Human med AG
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. MEDICAN CO., LTD
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. Hairline International
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development
    • 9.5.11. Genesis Biosystems, Inc.
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Product Portfolio
      • 9.5.11.3. Financial Overview
      • 9.5.11.4. Business Strategies and Development
    • 9.5.12. iXCells Biotechnologies USA, LLC
      • 9.5.12.1. Company Overview
      • 9.5.12.2. Product Portfolio
      • 9.5.12.3. Financial Overview
      • 9.5.12.4. Business Strategies and Development
    • 9.5.13. Kyocera Corporation
      • 9.5.13.1. Company Overview
      • 9.5.13.2. Product Portfolio
      • 9.5.13.3. Financial Overview
      • 9.5.13.4. Business Strategies and Development
    • 9.5.14. Medikan International Inc
      • 9.5.14.1. Company Overview
      • 9.5.14.2. Product Portfolio
      • 9.5.14.3. Financial Overview
      • 9.5.14.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations